- Report
- April 2025
- 194 Pages
Global
From €3969EUR$4,500USD£3,478GBP
- Report
- April 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,470GBP
- Report
- April 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,470GBP
- Report
- September 2025
- 250 Pages
Global
From €3960EUR$4,490USD£3,470GBP
- Report
- April 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,470GBP
- Report
- December 2025
- 279 Pages
Global
From €5160EUR$5,850USD£4,521GBP
- Report
- December 2025
- 278 Pages
Global
From €5160EUR$5,850USD£4,521GBP
- Report
- December 2025
- 490 Pages
Global
From €5160EUR$5,850USD£4,521GBP
- Report
- December 2025
- 475 Pages
Global
From €5160EUR$5,850USD£4,521GBP
- Report
- December 2025
- 285 Pages
Global
From €5160EUR$5,850USD£4,521GBP
- Report
- December 2025
- 373 Pages
Global
From €5160EUR$5,850USD£4,521GBP
- Report
- December 2025
- 262 Pages
Global
From €5160EUR$5,850USD£4,521GBP
- Report
- December 2025
- 194 Pages
Global
From €5160EUR$5,850USD£4,521GBP
- Report
- March 2025
- 180 Pages
Global
From €3969EUR$4,500USD£3,478GBP
- Report
- July 2025
- 217 Pages
Global
From €2205EUR$2,500USD£1,932GBP
- Report
- July 2025
- 226 Pages
Global
From €3925EUR$4,450USD£3,439GBP
- Report
- April 2025
- 150 Pages
Global
From €3396EUR$3,850USD£2,975GBP
€4278EUR$4,850USD£3,748GBP
- Report
- October 2025
- 150 Pages
Global
From €3396EUR$3,850USD£2,975GBP
- Report
- August 2025
- 150 Pages
Global
From €3396EUR$3,850USD£2,975GBP
- Report
- March 2025
- 150 Pages
Global
From €3396EUR$3,850USD£2,975GBP
€4278EUR$4,850USD£3,748GBP

The Adult Vaccine market is a segment of the larger Vaccine market, which focuses on providing immunizations to adults. Vaccines are used to protect adults from a variety of diseases, including influenza, hepatitis, and human papillomavirus. Vaccines are typically administered in a series of doses, and may require booster shots to maintain immunity. Vaccines are typically administered by healthcare professionals in a clinical setting, but some vaccines may be self-administered.
The Adult Vaccine market is highly competitive, with a variety of companies offering a range of products. Major players in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, and Johnson & Johnson. These companies offer a range of vaccines, including influenza, hepatitis, and human papillomavirus vaccines. Additionally, some companies offer combination vaccines, which provide protection against multiple diseases in a single dose. Show Less Read more